C WorldWide Group’s Heron Therapeutics HRTX Stock Holding History

C WorldWide Group’s Portfolio HRTX Stock Details HRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,202,069	Closed	-$3.35M	–	88
2022 Q2	$3.35M	Hold	1,202,069	–	–	0.04%	68
2022 Q1	$6.88M	Hold	1,202,069	–	–	0.07%	54
2021 Q4	$11M	Hold	1,202,069	–	–	0.1%	46
2021 Q3	$12.8M	Hold	1,202,069	–	–	0.13%	42
2021 Q2	$18.7M	Hold	1,202,069	–	–	0.19%	38
2021 Q1	$19.5M	Hold	1,202,069	–	–	0.19%	41
2020 Q4	$25.4M	Buy	1,202,069 +300,000	+33%	+$5.21M	0.25%	33
2020 Q3	$13.4M	Buy	902,069 +200,000	+28%	+$3.12M	0.15%	47
2020 Q2	$10.3M	Hold	702,069	–	–	0.12%	51
2020 Q1	$8.24M	Hold	702,069	–	–	0.12%	46
2019 Q4	$16.5M	Hold	702,069	–	–	0.2%	37
2019 Q3	$13M	Hold	702,069	–	–	0.16%	37
2019 Q2	$13.1M	Buy	702,069 +450,000	+179%	+$8.99M	0.16%	47
2019 Q1	$6.16M	Buy	252,069 +120,471	+92%	+$3.15M	0.08%	49
2018 Q4	$3.41M	Sell	131,598 -46,685	-26%	-$1.28M	0.05%	59
2018 Q3	$5.64M	Sell	178,283 -32,729	-16%	-$1.22M	0.07%	61
2018 Q2	$8.2M	Buy	211,012 +97,002	+85%	+$3.09M	0.11%	46
2018 Q1	$3.15M	Sell	114,010 -17,590	-13%	-$399K	0.05%	67
2017 Q4	$2.38M	Buy	131,600 +31,600	+32%	+$515K	0.03%	79
2017 Q3	$1.61M	Buy	+100,000	New	+$1.57M	0.02%	99

Other funds holding HRTX

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

C WorldWide Group's HRTX Position: Q3 2022 in Review

C WorldWide Group sold out of Heron Therapeutics (HRTX) in Q3 2022, closing a stake of 1,202,069 shares — an estimated $3.35M sold.

C WorldWide Group first reported a position in HRTX in Q3 2017 and held it in 20 quarters. The position peaked at $25.4M in Q4 2020. 186 funds tracked by Wall St. Rank hold HRTX as of Q3 2022.

C WorldWide Group reported no remaining Heron Therapeutics position as of Q3 2022 after selling out during the quarter.
C WorldWide Group sold 1,202,069 Heron Therapeutics shares in Q3 2022, an estimated $3.35M.
C WorldWide Group first reported a position in Heron Therapeutics in Q3 2017 and held it in 20 quarters.
C WorldWide Group's Heron Therapeutics position peaked at $25.4M in Q4 2020.
186 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2022.

Based on C WorldWide Group's 13F filing for Q3 2022, filed 3 Nov 2022.